logo

For the Inventor, By the Inventor

Uncasville, CT, United States of America

Erik Alphie LaChapelle

This inventor holds 24 USPTO granted patents and 5 published patent applications and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Pfizer Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Alphie LaChapelle. Retrieved from https://idiyas.com/inventor/erik-alphie-lachapelle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 66.7

 

Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 92(Granted Patents)


Location History:

  • Johnston, RI (US) (2014 - 2016)
  • Uncasville, CT (US) (2016 - 2024)

Company Filing History:

goldMedal24 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 2014-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Piperazine Derivatives
Phosphodiesterase Inhibitors
Toll-Like Receptor Agonists
Tricyclic Compounds
Dihydro-Pyrrolo-Pyridine
Imidazopyridazine
Pyrazolopyrimidine
Hexahydropyrano Compounds
Heteroaryl-Substituted
Carbocyclic Compounds
Thiazolyl Amides
24 patents (USPTO):Explore Patents
1. 12398119 - Piperazine azaspiro derivatives (2025-08-26),
2. 12049465 - Tricyclic compounds and their use as phosphodiesterase inhibitors (2024-07-30),
3. 11976064 - Toll-like receptor agonists (2024-05-07),
4. 11905284 - 5,7-dihydro-pyrrolo-pyridine derivatives (2024-02-20),
5. 11524954 - Piperazine azaspiro derivatives (2022-12-13),
6. 11472805 - Tricyclic compounds and their use as phosphodiesterase inhibitors (2022-10-18),
7. 11339159 - Toll-like receptor agonists (2022-05-24),
8. 11198692 - Dihydro-pyrrolo-pyridine derivatives (2021-12-14),
9. 10738063 - 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds (2020-08-11),
10. 10669279 - Imidazopyridazine compounds (2020-06-02),
11. 10604519 - 5,7-dihydro-pyrrolo-pyridine derivatives (2020-03-31),
12. 10323042 - 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds (2019-06-18),
13. 10131669 - Pyrazolopyrimidine compounds (2018-11-20),
14. 10077269 - Imidazopyridazine compounds (2018-09-18),
15. 10028962 - 2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2018-07-24),

Title: The Innovative Mind of Erik Alphie LaChapelle

Introduction: Erik Alphie LaChapelle is a renowned inventor hailing from Uncasville, CT (US), known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Erik Alphie LaChapelle holds several patents in the areas of renewable energy technologies, artificial intelligence, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Erik Alphie LaChapelle has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized various industries. His passion for innovation and problem-solving has led to the creation of numerous groundbreaking inventions.

Collaborations: Erik Alphie LaChapelle has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of creativity and collaboration that has resulted in the successful development of innovative technologies.

Conclusion: Erik Alphie LaChapelle's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a visionary inventor in the world of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…